http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-191102-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d5234b11a97551dee916609fdb11878 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9b83d53426d0a3dfbb69a8826ec116d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_abe292eeed1ebd6bc24ce0c099d46890 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ebc9e17639a220484adef660abebcfb http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_daf34d0455f91a35cf1f7f3492fde41e |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 |
| filingDate | 1980-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0b536df7080237bfce1ead107c39814 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c8f15eced1900dc2d34bbb6deb1de6c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6d015d136d3b6bc59b0ff7490eab411 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1587b22c2d13eb5d0af8857b55d3d51c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef514a92f264851705e2c0691ebb1c81 |
| publicationDate | 1987-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-191102-B |
| titleOfInvention | Process for producing pharmaceutical compositions of regulated dissolution of the active agents containing water-soluble inorganic pharmacons |
| abstract | The present invention relates to controlled-release, sustained-release and sustained release drug formulations comprising water-soluble granules, preferably 0.1-0.7 mm, for the production of controlled-release pharmaceutical compositions containing water-soluble inorganic pharmacons, preferably inorganic cations. a particulate solid active ingredient is homogeneously admixed with 0.1-1.0% fine dispersed hydrophobic pharmaceutical excipient, e.g., fine-divided silica, talc, magnesium stearate or zinc stearate, and the particles of this mixture are of a lipophilic material, preferably of a quality suitable for pharmaceutical purposes, or with a wax derivative such as white wax, kamaiwax, cetaceum or cetyl alcohol, or a pharmaceutical grade hydrophobic fatty acid ester such as glycerol monostearate or sorbitan fatty acid ester coated and coated in a manner known per se in capsules soluble in the gastrointestinal tract. -1- |
| priorityDate | 1980-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.